Cargando…

SUN-290 Responsiveness of Growth Hormone Therapy in a Patient with Complex Chromosome 4 q Interstitial Deletion

Background Information: Chromosome 4 q interstitial deletion is a rare chromosomal disorder characterized by post natal growth retardation, developmental delay, craniofacial dysmorphism and behavioral problems. Not only are the characteristics of growth failure in these patients ill defined, but the...

Descripción completa

Detalles Bibliográficos
Autor principal:	Haider, Anzar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553136/ http://dx.doi.org/10.1210/js.2019-SUN-290

Ejemplares similares

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

SAT-290 Expanded Phenotype Associated with RNF135 Intragenic Deletion in a Girl with Peripheral Precocious Puberty
por: Danowitz, Melinda, et al.
Publicado: (2019)

SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2019)

SUN-LB051 Low Alkaline Phosphatase? Rule out Growth Hormone Deficiency.
por: Bakhtiani, Priyanka, et al.
Publicado: (2019)

SUN-253 Effects of Growth Hormone Stimulation on the Immunologic Cellular Landscape in Pediatric Patients
por: Gujral, Jasmine, et al.
Publicado: (2019)

SUN-248 Growth Hormone Deficiency (GHD): Assessing Burden of Treatment in Children and Adolescents
por: Brod, Meryl, et al.
Publicado: (2019)

SUN-257 Adherence Rates to Growth Hormone Therapy: ECOS Study Analysis of Australian Data Compared with Global Adherence Rates
por: Reakes, Shannon, et al.
Publicado: (2019)

SUN-286 Growth Hormone Deficiency and Gingival Fibromatosis Due to Missense Mutation of KCNQ1
por: Dekelbab, Bassem, et al.
Publicado: (2019)

SUN-LB17 The Association of Growth Hormone Treatment in Children With Short Stature With Idiopathic Scoliosis
por: Nam, Hyo-Kyoung, et al.
Publicado: (2020)

SUN-258 Prediction of Height Two Years after Start Treatment in Children with Growth Hormone Deficiency
por: van Dommelen, Paula, et al.
Publicado: (2019)

SUN-249 Growth Hormone Utilization By US Youth: Trends as Insurance Pushes Back after FDA-Approved Expansion
por: Grimberg, Adda, et al.
Publicado: (2019)

PMON313 Hyperinsulinemic Hypoglycemia and Growth Hormone Deficiency Secondary to 20p11 Deletion
por: Wee, Erica, et al.
Publicado: (2022)

SUN-256 Limited Usefulness of Single IGF-I Measurement as a Screening Test for Growth Hormone Deficiency in Children and Adolescents
por: Ibba, Anastasia, et al.
Publicado: (2019)

SUN-288 Severe Growth Hormone Deficiency in a 13-Year-Old Girl with Congenital Eye Anomalies, Secondary to Transsphenoidal Encephalocele
por: Dekelbab, Bassem, et al.
Publicado: (2019)

SUN-060 Steroid Hormone Profile Differentiates Gynecomastia and Pseudo- Gynecomastia in Pubertal Boys
por: Reinehr, Thomas, et al.
Publicado: (2020)

PSAT104 Predicting Response to Growth Hormone Therapy with Pituitary Volume and The Growth Hormone Stimulation Test
por: McGuirk, Liam, et al.
Publicado: (2022)

SUN-245 Heterozygous GH1 p.R209H Variant within a Large Pedigree May Mimic a Growth Hormone Insensitivity Pattern
por: Sanguineti, Nora, et al.
Publicado: (2019)

SUN-078 Clinical, Hormonal, Psychosexual Aspects, Gonadal Tumors and Genetic Background of an Androgen Insensitivity Syndrome Cohort
por: Batista, Rafael Loch, et al.
Publicado: (2020)

THU170 Clinical And Immunological Response To Somatrogon In Two Siblings With A Homozygous Whole Gene Deletion Of The Growth Hormone 1 Gene
por: Gupta, Rahul, et al.
Publicado: (2023)

SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)
por: Savendahl, Lars, et al.
Publicado: (2019)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SUN-254 A Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human Growth Hormone (rhGH), in Short Children Born Small for Gestational Age (SGA)
por: Schwarz, Hans-Peter, et al.
Publicado: (2019)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

SUN-085 Clinical and Hormonal Features of 37 Families with Central Precocious Puberty Due to MKRN3 Loss-Of -Function Mutations
por: Seraphim, Carlos Eduardo, et al.
Publicado: (2020)

SUN-099 Seasonal Variations of 25-Hydroxy Vitamin D3, Parathyroid Hormone, and Alkaline Phosphatase in School-Aged Children
por: Menendez, Gonzalo Alfonso Dominguez, et al.
Publicado: (2020)

SUN-077 Do Low Sex Hormone Binding Globulin Levels in Newborns Predict Weight Gain in Infancy and Early Childhood?
por: Aydin, Banu Kucukemre, et al.
Publicado: (2020)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

Hyponatremia: An Unusual Presentation in a Neonate With Chromosome 1q21.1 Deletion Syndrome
por: Alzarka, Bakri, et al.
Publicado: (2018)

SUN-266 Anti-Mullerian Hormone as a Marker of Ovarian Reserve in Female Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Badia, Priscila, et al.
Publicado: (2019)

Factors Driving Patient Preferences for Growth Hormone Treatment in Japanese Children With Growth Hormone Deficiency
por: Tanaka, Toshiaki, et al.
Publicado: (2021)

Long-Term Growth Hormone Therapy Does Not Advance Skeletal Maturation in Children and Adolescents
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2021)

Growth Hormone Therapy for Children With Duchenne Muscular Dystrophy and Glucocorticoid Induced Short Stature
por: Lavi, Eran, et al.
Publicado: (2021)

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

OR10-05 Phase 3 FliGHt Trial: Experience of Switching from Daily Growth Hormone Therapy to Once-Weekly TransCon HGH in Children with Growth Hormone Deficiency
por: Maniatis, Aristides K, et al.
Publicado: (2020)

THU166 A Minimum Data Set For The Monitoring Of Recombinant Human Growth Hormone (rhGH) Therapy In Children With Growth Hormone Deficiency (GHD)—A GloBE-Reg Initiative
por: Chen, Suet Ching, et al.
Publicado: (2023)

SAT-088 The Incidence of Neurological Symptoms During Growth Hormone Therapy in Patients with Chiari Malformation
por: Alexandrov, Alice, et al.
Publicado: (2020)

SUN-287 Pituitary Gigantism Presenting as Anxiety
por: Velasco, Jacqueline, et al.
Publicado: (2019)

SUN-055 Prenatal Exposure to Artificial Sweeteners
por: Halasa, Brianna C, et al.
Publicado: (2020)

SUN-267 Relationship between Height Velocity and Change of Serum Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Concentrations during Gonadotropin-Releasing Hormone Agonist Treatment in Korean Girls with Idiopathic Central Precocious Puberty
por: Yang, Seung, et al.
Publicado: (2019)

SUN-255 PATRO Children, a Multi-Center, Non-Interventional Study of the Long-Term Safety and Efficacy of Omnitrope® in Children Requiring Growth Hormone Treatment: Comparing United States (US) and Rest of World (ROW) Data
por: Backeljauw, Philippe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cd3huceov6saduobe6g2526ii2